Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia.

ABSTRACT:

SUBMITTER: Hengeveld PJ 

PROVIDER: S-EPMC10317999 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature